Skip to main content
. 2022 Mar 12;75(9):1573–1584. doi: 10.1093/cid/ciac210

Table 1.

Characteristics of Healthcare Workers

Characteristic Overall, No. (%)a (N = 2435) Baseline prevalent COVID-19 cases, No. (%)a (n = 21) Incident Cohort
Negative, No. (%)a (n = 2344) Incident COVID-19 cases, No. (%)a (n = 70) SMDb
Follow-up time, person-years 779 0 750 17.5 0.60
Age, mean (SD), y 40.4
(10.1)
42.7(13.0) 40.4
(10.05)
40.6
(11.73)
0.02
Health system
 SHC 891 (36.6) 5 (23.8) 855 (36.5) 31 (44.3) 0.16
 UCSF Health 826 (33.9) 7 (33.3) 798 (34.0) 21 (30.0)
 ZSFGH 718 (29.5) 9 (42.9) 691 (29.5) 18 (25.7)
Female sex 1923 (79.0) 13 (61.9) 1855 (79.1) 55 (78.6) 0.11
Latinx ethnicity
 No 2036 (87.8) 17 (100.0) 1960 (87.7) 7 (10.6) 0.12
 Yes 267 (11.5) 0 (0.0) 260 (11.6) 7 (10.6)
 Decline to answer 15 (0.6) 0 (0.0) 15 (0.7) 0 (0.0)
Race
 White 1411 (60.9) 9 (52.9) 1364 (61.1) 38 (57.6) 0.14
 Asian 530 (22.9) 3 (17.6) 511 (22.9) 16 (24.2)
 Black 37 (1.6) 1 (5.9) 34 (1.5) 2 (3.0)
 Multiracial 137 (5.9) 3 (17.6) 131 (5.9) 3 (4.5)
 Other 143 (6.2) 0 (0.0) 138 (6.2) 5 (7.6)
 Decline to answer 58 (2.5) 1 (5.9) 55 (2.5) 2 (3.0)
Highest educational level
 Less than college 33 (1.4) 0 (0.0) 33 (1.5) 0 (0.0) 0.29
 College 1006 (43.4) 6 (35.3) 967 (43.3) 33 (50.0)
 Higher than college 1264 (54.5) 11 (64.7) 1222 (54.7) 31 (47.0)
 Other 15 (0.6) 0 (0.0) 13 (0.6) 2 (3.0)
Comorbid conditions
 None reported 1642 (71.5) 12 (70.6) 1582 (71.5) 48 (72.7) 0.03
 Asthma or COPD 328 (14.3) 3 (17.6) 314 (14.2) 11 (16.7) 0.07
 Diabetes mellitus, heart disease, high blood pressure, or severe obesity 266 (11.6) 2 (11.8) 258 (11.7) 6 (9.1) 0.08
 Kidney disease on dialysis, liver disease, cancer, autoimmune
disorder, or neurological disease
161 (7.0) 1 (5.9) 154 (7.0) 6 (9.1) 0.08
Job role
 Registered nurse or nurse manager 1077 (44.2) 8 (38.1) 1035 (44.2) 34 (48.6) ~
 Clinician (MD, MD-equivalent, APP, or trainee) 804 (33.0) 8 (38.1) 780 (33.3) 16 (22.9)
 Research/administrative 115 (4.7) 1 (4.8) 113 (4.8) 1 (1.4)
 Support service 112 (4.6) 0 (0.0) 110 (4.7) 2 (2.9)
 Assistant or phlebotomist 84 (3.4) 1 (4.8) 80 (3.4) 3 (4.3)
 Laboratory or pharmacist 77 (3.2) 1 (4.8) 73 (3.1) 3 (4.3)
 Care coordination 71 (2.9) 0 (0.0) 65 (2.8) 6 (8.6)
 Clinic manager or ward clerk 45 (1.8) 2 (9.5) 42 (1.8) 1 (1.4)
 Respiratory or speech therapist 33 (1.4) 0 (0.0) 31 (1.3) 2 (2.9)
 Environmental/food services 17 (0.7) 0 (0.0) 15 (0.6) 2 (2.9)
Work duties
 Direct patient care involved in intubating or suctioning patient airways 701 (30.2) 6 (35.3) 670 (30.0) 25 (37.9) 0.30
 Direct patient care but not performing any airway procedures 1220 (52.6) 10 (58.8) 1178 (52.7) 32 (48.5)
Staff with indirect patient contact (eg, reception, environmental services) 128 (5.5) 0 (0.0) 127 (5.7) 1 (1.5)
 Laboratory 58 (2.5) 0 (0.0) 55 (2.5) 3 (4.5)
 Work in healthcare but not with patients or biological samples 81 (3.5) 1 (5.9) 78 (3.5) 2 (3.0)
 Other 131 (5.6) 0 (0.0) 128 (5.7) 3 (4.5)
Performed AGPc 385 (16.0) 3 (18.8) 368 (15.9) 14 (20.0) 0.11
COVID-19 exposure at work
 No exposure 942 (38.9) 8 (47.1) 908 (38.9) 26 (37.1) 0.28
 Low-risk exposured 680 (28.1) 6 (35.3) 661 (28.3) 13 (18.6)
 High-risk exposured 797 (32.9) 3 (17.6) 763 (32.7) 31 (44.3)
Time spent in the healthcare workplace
 0 h/wk 28 (1.2) 0 (0.0) 28 (1.2) 0 (0.0) 0.26
 <10 h/wk 90 (3.7) 2 (11.8) 85 (3.6) 3 (4.3)
 10–20 h/wk 169 (7.0) 1 (5.9) 165 (7.1) 3 (4.3)
 21–30 h/wk 296 (12.2) 0 (0.0) 287 (12.3) 9 (12.9)
 31–40 h/wk 1148 (47.5) 5 (29.4) 1104 (47.3) 39 (55.7)
 >40 h/wk 688 (28.4) 9 (52.9) 663 (28.4) 16 (22.9)
Time spent providing direct patient-facing care
 0 h/wk 234 (9.7) 1 (5.9) 226 (9.7) 7 (10.0) 0.38
 <10 h/wk 305 (12.6) 3 (17.6) 299 (12.8) 3 (4.3)
 10–20 h/wk 400 (16.5) 4 (23.5) 386 (16.6) 10 (14.3)
 21–30 h/wk 397 (16.4) 0 (0.0) 381 (16.3) 16 (22.9)
 31–40 h/wk 825 (34.1) 5 (29.4) 791 (33.9) 29 (41.4)
 >40 h/wk 258 (10.7) 4 (23.5) 249 (10.7) 5 (7.1)
No. in household, mean (SD) 2.3 (17.2) 1.5 (1.1) 2.3 (1.7) 2.3 (1.9) 0.02
Any children aged <18 y in household 841 (36.5) 2 (11.8) 817 (36.8) 22 (33.8) 0.06
Any adults aged ≥65 y in household 256 (11.1) 1 (5.9) 245 (11.0) 10 (15.4) 0.13
Extent of avoiding contact with people who live outside your home
 All of the time 80 (3.3) 2 (11.8) 72 (3.1) 6 (8.6) 0.34
 Most of the time; I only leave my home to buy food or other essentials or to walk/exercise 1232 (50.9) 8 (47.1) 1197 (51.3) 27 (38.6)
 Some of the time; I have reduced the amount of time I am in public spaces, social gatherings, or at work 1096 (45.3) 7 (41.2) 1052 (45.1) 37 (52.9)
 None of the time 11 (0.5) 0 (0.0) 11 (0.5) 0 (0.0)
Frequency of mask wearing when leaving home
 All of the time 1778 (73.5) 10 (58.8) 1719 (73.7) 49 (70.0) 0.25
 Most of the time 621 (25.7) 7 (41.2) 596 (25.6) 18 (25.7)
 Some of the time 17 (0.7) 0 (0.0) 14 (0.6) 3 (4.3)
 Never 3 (0.1) 0 (0.0) 3 (0.1) 0 (0.0)
Had community exposure with a person who tested positive for COVID-19 176 (7.3) 1 (5.9) 158 (6.8) 17 (24.3) 0.50
Spent time in another country/state 825 (34.1) 3 (17.6) 798 (34.2) 24 (34.3) <0.01

Abbreviations: AGPs, aerosol-generating procedures; APP, advanced practice providers; COPD, chronic obstructive pulmonary disease; COVID-10, coronavirus disease 2019; MD, medical doctor; SD, standard deviation; SHC, Stanford Health Care; SMD, standardized mean difference; UCSF, University of California, San Francisco; ZSFGH, Zuckerberg San Francisco General Hospital.

Data represent no. (%) of healthcare workers, unless otherwise stated.

The SMD is a comparative measure of effect size between groups. The magnitude of effect is considered small if the SMD is 0.2, medium at 0.5, and large at 0.8.

AGPs include intubation, extubation, chest physiotherapy, noninvasive ventilation, open suction, nebulized medications, manual ventilation, bronchoscopy, pulmonary function tests, high-frequency ventilation, laryngoscopy, autopsy, cardiopulmonary resuscitation, tracheostomy, and high-flow nasal cannula use.

Low-risk exposure at work included interacting with a patient who had COVID-19, with no reported breach in personal protective equipment (PPE) or other safety protocols. High-risk exposure included ever interacting with a patient who had COVID-19, without wearing full PPE or with a breach in any safety protocol.